<s>[INST] The next text is a question of a member of the European parliament:"In the 2008 EU Multiple Sclerosis (MS) Barometer, Romania ranks 32 out of 32countries.  The MS barometer is a benchmarking initiative that measures care and services for people with the condition in seven key areas, including access to treatment and therapies, research into MS, employment and job retention, and medication coming onto the market. Figures for 2008 collected in each country by national MS organisations and medical advisory boards showed major differences between the 32European countries taking part (27 EU Member States plus five others). The average score was 156 out of a total of 270points across the seven areas of MS care assessed, but this ranged from the highest score of 240 in Germany down to the lowest of 82points in Romania.   Does the Commission think that there is a need for action at European level, in the interests of European citizens, to eliminate the disparities in diagnosis and treatment which exist in the Member States?"
Analyze carefully the text and assign it to the most relevant policy area among those listed below. Do not explain your answer and return only a number.
Policy area numbers: 1 = Macroeconomics
2 = Civil Rights, Minority Issues and Civil Liberties
3 = Health
4 = Agriculture and Fisheries
5 = Labour, employment and pensions
6 = Education
7 = Environment
8 = Energy
9 = Immigration
10 = Transportation
12 = Law and Crime
13 = Social welfare
14 = Regional and Urban issues and Planning
15 = Banking, finance and domestic commerce issues
16 = Defence
17 = Space, science, technology, and communications issues
18 = Foreign trade
19 = International affairs and foreign aid
20 = Governance and government
21 = Public Lands, Water Management and Territorial Issues
23 = Culture and media
[/INST]. Answer = [3]. </s>
In the 2008 EU Multiple Sclerosis (MS) Barometer, Romania ranks 32 out of 32countries.  The MS barometer is a benchmarking initiative that measures care and services for people with the condition in seven key areas, including access to treatment and therapies, research into MS, employment and job retention, and medication coming onto the market. Figures for 2008 collected in each country by national MS organisations and medical advisory boards showed major differences between the 32European countries taking part (27 EU Member States plus five others). The average score was 156 out of a total of 270points across the seven areas of MS care assessed, but this ranged from the highest score of 240 in Germany down to the lowest of 82points in Romania.   Does the Commission think that there is a need for action at European level, in the interests of European citizens, to eliminate the disparities in diagnosis and treatment which exist in the Member States?